Here is Why H.C. Wainwright Sees Immense Upside for Viking Therapeutics (VKTX) [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
Wainwright analyst Joseph Pantginis reaffirmed his Buy rating on Viking Therapeutics (NASDAQ:VKTX). The analyst has forecasted a huge upside potential of almost 190% from the prevailing range, with a price target of $102 a share. oatautta/Shutterstock.com Pantginis maintains a long-term view based on the company's differentiated VK2735 oral and injectable formulations. This view comes after some positive outcomes of the Phase 3 ATTAIN-MAINTAIN study, based on the same molecule, conducted by their competitor Eli Lilly. The results indicate that the oral therapies are equally effective in preserving the weight loss, which previously was associated with injections. This would facilitate a highly smooth transition from injections to oral therapies for chronic treatments, without much risk. These results from Eli Lilly's study validate the ongoing efforts on Viking's oral obesity program. Apart from curtailing the commercial risks associated with the program, they will also increase
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Viking Therapeutics, Inc. (VKTX): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics (VKTX): Rethinking Valuation After a Sharp Pullback and Strong Multi-Year Run [Yahoo! Finance]Yahoo! Finance
- 1 Bold Prediction for Viking Therapeutics in 2026 [Yahoo! Finance]Yahoo! Finance
- This is why Viking Therapeutics, Inc. (VKTX) is a Strong Buy on Wall Street [Yahoo! Finance]Yahoo! Finance
- Unusual Bullish Options Activity Could Be A Game Changer For Viking Therapeutics (VKTX) [Yahoo! Finance]Yahoo! Finance
VKTX
Earnings
- 10/22/25 - Miss
VKTX
Sec Filings
- 11/5/25 - Form SCHEDULE
- 10/28/25 - Form 4
- 10/28/25 - Form 4
- VKTX's page on the SEC website